KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E Adjustments
Ratios

TherapeuticsMD (TXMD) Short-Term Debt issuances (2020)

Historic Short-Term Debt issuances for TherapeuticsMD (TXMD) over the last 4 years, with Q1 2020 value amounting to $50.0 million.

  • TherapeuticsMD's Short-Term Debt issuances changed N/A to $50.0 million in Q1 2020 from the same period last year, while for Dec 2020 it was $50.0 million, marking a year-over-year increase of 4990000.0%. This contributed to the annual value of $50.0 million for FY2020, which is 7500.0% down from last year.
  • Latest data reveals that TherapeuticsMD reported Short-Term Debt issuances of $50.0 million as of Q1 2020.
  • TherapeuticsMD's Short-Term Debt issuances' 5-year high stood at $50.0 million during Q1 2020, with a 5-year trough of $50.0 million in Q1 2020.